<DOC>
	<DOCNO>NCT00979628</DOCNO>
	<brief_summary>High blood glucose level medical surgery patient diabetes associate increased risk in-hospital complication death . Improved glucose control insulin injection may improve clinical outcome prevent hospital complication . Numerous study show high blood glucose increase risk wound infection , kidney failure death . It know ; however , best insulin regimen patient undergo surgery . The use repeat injection regular insulin commonly use glucose control hospitalize patient diabetes . Recently , combination Lantus® Apidra® insulins show improve glucose control lower rate hypoglycemia ( low blood sugar ) . The investigator ' recent preliminary data also indicate single daily dose glargine plus corrective dos glulisine meal need ( Basal Plus ) effective management medical surgical patient type 2 diabetes mellitus ( T2DM ) . The average daily blood glucose ( BG ) level patient treat Basal Plus equivalent level patient treat Basal Bolus glargine daily plus glulisine meal ( basal bolus regimen ) . The mean daily BG level patient treat basal plus low report patient treat slide scale regular insulin ( SSRI ) . Accordingly , present study aim determine insulin treatment best glucose control hospitalize patient diabetes admit general medicine ward . Glargine , glulisine , regular insulin approve use treatment patient diabetes FDA .</brief_summary>
	<brief_title>Basal Bolus Versus Basal Insulin Type 2 Diabetes Mellitus ( DM )</brief_title>
	<detailed_description>A total 375 subject type 2 diabetes recruit study . The site study Grady Memorial Hospital , Emory University Hospital , Atlanta VA Medical Center , Scott &amp; White Memorial Hospital Clinic , Medical University South Carolina .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Males female age 18 75 year admit general medicine surgical service . A known history type 2 diabetes mellitus &gt; 3 month , receive either diet alone , oral monotherapy , combination oral antidiabetic agent ( sulfonylurea , meglitinides , metformin , thiazolidinediones , DPPIV inhibitor ) . Patients admit noncardiac elective emergency surgery trauma . Subjects must admission BG &gt; 140 mg &lt; 400 mg/dL without laboratory evidence diabetic ketoacidosis ( bicarbonate &lt; 18 mEq/L , pH &lt; 7.30 , positive serum urinary ketone ) . Subjects increase blood glucose concentration , without know history diabetes ( stress hyperglycemia ) . Subjects history diabetic ketoacidosis hyperosmolar hyperglycemic state , ketonuria [ 32 ] . Patients acute critical surgical illness admit ICU expect require admission ICU . Patients admit CABG patient receive continuous insulin infusion . Patients clinically relevant hepatic disease ( diagnose liver cirrhosis portal hypertension ) , corticosteroid therapy , impaired renal function ( creatinine ≥ 3.0 mg/dl ) . Mental condition render subject unable understand nature , scope , possible consequence study . Female subject pregnant breast feeding time enrollment study . Patients recognize suspected endocrine disorder associate increased insulin resistance , acromegaly , hyperthyroidism . Female subject pregnant breast feeding time enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Inpatient Hyperglycemia</keyword>
</DOC>